JAK2 and nasopharyngeal carcinoma: For example, activation of Janus kinase 2 (JAK2)/STAT3 pathway has been shown to suppress miRNA-1 expression by inhibiting miRNA-1 promoter activity in nasopharyngeal carcinoma (52).